All Cardiovascular articles
-
Guidance cardNICE Technology Appraisal 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed the card for technical accuracy and regulatory compliance and supplied the prescribing information.
-
NICE guideline
NICE hypertension guideline
A brief guide on the diagnosis and management of hypertension, includes visual summaries on treatment and choice of antihypertensive drug.
-
NICE guideline
NICE stroke and TIA guideline
This concise summary covers the rapid recognition of symptoms and diagnosis of stroke and transient ischaemic attack.
-
NICE guideline
NICE hypertension in pregnancy guideline
This summary covers the diagnosis and management of hypertension during pregnancy, labour, and birth.
-
SIGN guideline
SIGN cardiac arrhythmias guideline
Read the latest recommendations on the management of atrial fibrillation and ventricular arrhythmias in acute coronary syndrome, coronary heart disease, and left-ventricular dysfunction as well as arrhythmias associated with cardiac arrest and coronary artery bypass graft.
-
Sponsored algorithm
Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment
This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.
-
Working party guideline/algorithm
Stable peripheral arterial disease guideline
This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.
-
Working party guideline/algorithm
Stable coronary artery disease guideline
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.
-
NICE guideline
NICE chronic heart failure guideline
This summary of the NICE heart failure guideline covers management and monitoring treatment. Includes algorithms on diagnosis and therapies.
-
SIGN guideline
SIGN stable angina guideline
This summary includes management algorithms for patients with suspected angina, and patients with a definite diagnosis of stable angina.
-
News
SIGN updates guideline on stable angina
The Scottish Intercollegiate Guidelines Network (SIGN) has published SIGN 151 on Management of stable angina.
-
Independent professional body guideline
Management of palpitations in primary care guideline
How do you manage palpitations in primary care? This summary covers assessment and examination, risk stratification, and indications for referral.
-
News
Quality standard on AF updated by NICE
NICE has updated Quality Standard 93 on Atrial fibrillation.
-
NICE guideline
NICE FH guideline
Summary of NICE guidance on the identification and management of familial hypercholesterolaemia, which includes diagnostic criteria and when to refer.
-
SIGN guideline
SIGN CVD guideline
This summary covers estimation of cardiovascular event risk, lifestyle interventions, and pharmacological therapy.
-
News
SIGN releases updated guidance on cardiovascular disease
The Scottish Intercollegiate Guidelines Network (SIGN) has published SIGN 149 Risk estimation and the prevention of cardiovascular disease and SIGN 150 Cardiac rehabilitation. SIGN 149
-
Working party guideline/algorithm
Management of patients with non-valvular atrial fibrillation uncontrolled on warfarin guideline
This management algorithm was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer.
-
NICE guideline
NICE transient loss of consciousness guideline
This concise and useful summary covers the assessment and referral of people who have had a transient loss of consciousness (‘blackout’)
-
NICE guideline
NICE chest pain guideline
An easy-to-read guideline summary on the assessment and diagnosis of acute and stable chest pain, including management and referral for suspected ACS.
-
NICE guideline
NICE CVD guideline
A concise summary of NICE's evidence-based clinical guideline on lipid modification for the prevention of cardiovascular disease.
![ECG recording [green]](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/100x67//0/9/7/3097_ECG-2-640x429.jpg)
